Medtecs International Corporation Ltd
SGX:546
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Medtecs International Corporation Ltd
Current Portion of Long-Term Debt
Medtecs International Corporation Ltd
Current Portion of Long-Term Debt Peer Comparison
1786
4155
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
M
|
Medtecs International Corporation Ltd
SGX:546
|
Current Portion of Long-Term Debt
$801k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
-31%
|
|
V
|
Visco Vision Inc
TWSE:6782
|
Current Portion of Long-Term Debt
NT$191.4m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
P
|
Pegavision Corp
TWSE:6491
|
Current Portion of Long-Term Debt
NT$149.7m
|
CAGR 3-Years
53%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
SciVision Biotech Inc
TWSE:1786
|
Current Portion of Long-Term Debt
NT$1.2m
|
CAGR 3-Years
-84%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
OK Biotech Co Ltd
TWSE:4155
|
Current Portion of Long-Term Debt
NT$82.8m
|
CAGR 3-Years
78%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
See Also
What is Medtecs International Corporation Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
801k
USD
Based on the financial report for Dec 31, 2023, Medtecs International Corporation Ltd's Current Portion of Long-Term Debt amounts to 801k USD.
What is Medtecs International Corporation Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
-31%
Over the last year, the Current Portion of Long-Term Debt growth was 39%. The average annual Current Portion of Long-Term Debt growth rates for Medtecs International Corporation Ltd have been -14% over the past three years , -53% over the past five years , and -31% over the past ten years .
You don't have any saved screeners yet
